
Bumps on ancient, armored fish may have given rise to teeth in animals, study finds
The sensitive interior of human teeth might have originated from a seemingly unlikely place: sensory tissue in fish that were swimming in Earth's oceans 465 million years ago.
While our teeth are covered in hard enamel, it's dentine — the tooth's inner layer responsible for carrying sensory information to the nerves — that reacts to the pressure of a hard bite, pain, or changes like extreme cold or sweetness.
When trying to determine the origins of teeth, one of the many possibilities considered by researchers over the years was that teeth may have evolved from bumps on the armored exoskeletons on ancient fish. But the true purpose of the structures, called odontodes, was unclear.
Now, a new study and 3D scans of fossils have yielded evidence that the external bumps contained dentine, which likely helped fish sense their surroundings. Scientists reported the findings Wednesday in the journal Nature.
'Covered in these sensitive tissues, maybe when it bumped against something it could sense that pressure, or maybe it could sense when the water got too cold and it needed to swim elsewhere,' said lead study author Dr. Yara Haridy, postdoctoral researcher in the department of organismal biology and anatomy at the University of Chicago, in an email.
During its analysis, the team also uncovered similarities between the odontodes and features called sensilla, which exist as sensory organs in the shells of modern animals such as crabs and shrimp, and can be found in fossilized invertebrate arthropods. The development of odontodes in fish, which are vertebrates, and sensilla in arthropods, which are invertebrates, is a prime example of evolutionary convergence — when similar features evolve independently in different animal groups, Haridy said.
'These jawless fish and Aglaspidid arthropods (extinct marine arthropods) have an extremely distant shared common ancestor that likely had no hard parts at all,' Haridy said. 'We know that vertebrates and arthropods evolved hard parts independently and amazingly they evolved similar sensory mechanisms integrated into their hard skeleton independently.'
While arthropods have retained their sensilla, odontodes appear to be the direct precursors to teeth in animals.
As the researchers compared sensilla and odontodes, they also arrived at another finding: One species, once considered to be an ancient fish, was actually an arthropod.
Haridy's original aim was to solve the mystery of the oldest vertebrate animal that exists in the fossil record. She approached museums across the country and asked whether she could scan any fossil specimens they had from the Cambrian Period, 540 million years to 485 million years ago.
Then, she settled in for an all-nighter at the Argonne National Laboratory, where she used their Advanced Photon Source to capture high-resolution computer tomography, or CT, scans.
'It was a night at the particle accelerator; that was fun,' Haridy said.
At first glance, a fossil of a creature called Anatolepis looked like a vertebrate fish – and indeed, previous research from 1996 had identified it as one. Haridy and her colleagues noticed that there was a series of pores filled with a material that appeared to be dentine.
'We were high fiving each other, like 'oh my god, we finally did it,'' Haridy said. 'That would have been the very first tooth-like structure in vertebrate tissues from the Cambrian. So, we were pretty excited when we saw the telltale signs of what looked like dentine.'
To confirm their discovery, the team compared the scans with those of other ancient fossils, as well as modern crabs, snails, beetles, sharks, barnacles and even miniature suckermouth catfish that Haridy had raised herself.
Those comparisons showed that Anatolepis more closely resembled arthropod fossils, including one from the Milwaukee Public Museum. And what the team thought were tubules lined with dentine were actually more similar to sensilla.
But they did find dentine-containing odontodes in ancient fish like Eriptychius and Astraspis during the scans.
The confusion over Anatolepis' true nature had stemmed from the fragmentary nature of the fossils. The most complete pieces are only about 3 millimeters (0.1 inches) in size, Haridy said, which proved to be a challenge for comparative research reliant on external imaging.
But the new scans she conducted enabled a 3D look at the fossils, revealing their internal anatomy.
'This shows us that 'teeth' can also be sensory even when they're not in the mouth,' Haridy said. 'So, there's sensitive armor in these fish. There's sensitive armor in these arthropods. This explains the confusion with these early Cambrian animals. People thought that this was the earliest vertebrate, but it actually was an arthropod.'
The cutting edge modern imaging used in the study is resolving the debate over Anatolepis, said Dr. Richard Dearden, a postdoctoral research fellow at the Naturalis Biodiversity Center in Leiden, the Netherlands. Dearden was not involved in the new research.
'(The study authors) use cutting edge modern imaging approaches to try and settle this question, assembling an impressive swathe of comparative data to convincingly establish that Anatolepis is indeed not a vertebrate,' Dearden said in an email.
Armored jawless fish like Astraspis and Eriptychius and ancient arthropods like Anatolepis coexisted in the muddy shallow seas of the Ordovician period, which occurred between 485.4 million and 443.8 million years ago.
Other contemporaries of these animals included large cephalopods such as giant squid, as well as huge sea scorpions. Features like odontodes and sensilla would help fish and arthropods distinguish predators from prey.
'When you think about an early animal like this, swimming around with armor on it, it needs to sense the world. This was a pretty intense predatory environment and being able to sense the properties of the water around them would have been very important,' said senior study author Dr. Neil Shubin, the Robert R. Bensley Distinguished Service Professor of Organismal Biology and Anatomy at the University of Chicago, in a statement. 'So, here we see that invertebrates with armor like horseshoe crabs need to sense the world too, and it just so happens they hit on the same solution.'
Several modern fishes have odontodes, while sharks, skates and some catfishes are covered in small toothlets called denticles, which cause their skin to feel like sandpaper, Haridy said.
Haridy studied the tissues of the catfish she raised and realized their denticles were connected to nerves much in the same way that teeth are in animals. When comparing teeth, odontodes and sensilla, they were all incredibly similar, she said.
'We think that the earliest vertebrates, these big, armored fish, had very similar structures, at least morphologically. They look the same in ancient and modern arthropods, because they're all making this mineralized layer that caps their soft tissue and helps them sense the environment,' Haridy said.
It's likely that the genes necessary to form odontodes also produced sensitive teeth in animals — including humans — later, according to the study authors.
The findings support the idea that sensory structures appeared first on exoskeletons, which then provided the genetic information that could then be used to create teeth as they became a necessary part of life, the study authors noted.
'Over time, fish evolved jaws, and it became advantageous to have pointy structures around and in the mouth,' Haridy said. 'Little by little some fish with jaws had pointy odontodes at the edge of the mouth and then eventually some were directly in the mouth and then lost across the body. The relationship between odontodes and teeth is continuously being clarified by new fossils and modern genetics.'
The new research refines the timeline for the first appearance of hard tissues and the earliest ancestors of jawed fishes by removing Anatolepis from the fish tree of life, said Dr. Lauren Sallan, assistant professor and head of the macroevolution unit at the Okinawa Institute of Science and Technology in Japan. Sallan, who was not involved in the new study, said it also raises an intriguing new hypothesis that the scalelike precursors of teeth evolved to detect prey, friends or predators in the water.
'This is a real challenge to seemingly obvious assumptions that hard tissues like dentine and structures like scales and teeth evolved (primarily) for protection on the body or feeding in the throat,' Sallan said. 'Instead, they may have been 'exapted' (subsequently modified) for these uses, much like how limbs evolved before they were used to walk on land. It's also interesting to see the degree of convergence between early armored arthropods and fishes, and raises questions about how much ecological overlap occurred between these two groups.'
Haridy wants to continue the search for fossils that could lead to the oldest vertebrate, given that researchers expect there are earlier vertebrates than Astraspis and Eriptychius. And even though they didn't discover it through this research, they made worthwhile findings, Shubin said in an email.
'We were disappointed that (Anatolepis) wasn't a vertebrate but we were amazed by the new ideas that arose,' Shubin said. 'And that took us in an entirely new direction. That's science.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
an hour ago
- Forbes
U.S. Seniors Nearly Double Cannabis Use In Just Two Years, Study Finds
U.S. Seniors are turning to cannabis more than ever, with use nearly doubling in the past two years, a new study shows. Published this week in JAMA Internal Medicine, four researchers from the University of California and NYU Langone Health found that monthly cannabis use among adults aged 65 and older increased from 4.8% in 2021 to 7% in 2023, resulting in a 45.83% increase. The reasons for this increase are attributed to several factors, including greater access to cannabis. As of today, medical cannabis is legal in 39 states and Washington D.C., while 24 states have also legalized it for recreational use. The situation was slightly different in 2021, when medical cannabis was legal in 36 states and recreational use was legal in 17 states. In 2021, New York, Virginia, New Mexico, and Connecticut legalized cannabis for recreational use. The rise in access to cannabis, both medical and recreational, helps explain why more older adults are using it, especially as more people become aware of medical programs and the health issues cannabis can help treat. This cross-sectional study analyzed 15,689 adults aged 65 and older using data from the National Survey on Drug Use and Health (NSDUH), a nationwide survey of people in the U.S. who aren't living in institutions. The findings show that, between 2021 and 2023, cannabis use among older adults in the U.S. saw a significant rise, with some groups showing especially sharp increases. People with a college or postgraduate degree, for example, went from 4.9% to 8.3% in cannabis use. Among those earning $75,000 or more, cannabis use more than doubled, from 4.2% to 9.1%. Married adults also showed a big jump, going from 3.8% to 7.4%. Older adults living in states where medical cannabis is legal were more likely to use it, and that number kept climbing from 5.4% to 7.9%. 'It shouldn't be surprising that use is becoming increasingly more common among people who live in states that allow medical cannabis, which could be due to increased availability or social acceptability,' said Joseph Palamar, the study's senior author in a press statement, adding that 'with respect to income, those with the highest incomes had the lowest prevalence of cannabis use in 2021, but by 2023 this group had the highest prevalence, which may indicate who has access to medical cannabis given its costs.' The most dramatic increase came from people with chronic obstructive pulmonary disease (COPD), whose usage doubled from 6.4% to 13.5%. People with chronic conditions like cancer, diabetes, heart disease, and high blood pressure also reported using cannabis more. And those dealing with two or more chronic illnesses saw use rise from 3.5% to 8.2%. The authors of this study concluded that these findings show a real shift in how older adults are using cannabis, especially those living with chronic illnesses, and that people with multiple health conditions were more likely to use it. However, they also highlighted that 'the use of cannabis products, especially with psychoactive properties, may complicate chronic disease management among older adults.' These new findings line up with what earlier studies have shown. Back in 2020, a study published in the same journal looked at data from nearly 15,000 adults over 65 using the same national survey and found that cannabis use among older adults had already been on the rise for years, jumping from just 0.4% in 2006 and 2007 to 2.9% by 2015 and 2016. In recent years, researchers have also started to study how long-term cannabis use affects older adults. For example, a study published last year suggested that taking low doses of THC over time may not only help protect the brain from aging but also boost memory, improve cognitive function, and support seniors's overall well-being and longevity. This likely has to do with a key cellular pathway called mTOR, which is a protein that helps control how cells use energy and build new connections in the brain, which are important for learning and memory.


Forbes
an hour ago
- Forbes
Experts Warn Of Decade-Long Setback After Trump Cuts HIV Vaccine Research
NEW YORK - DECEMBER 1: Marina Kemelman, Research Associate at the AIDS Vaccine Design and ... More Development Laboratory, collects bacteria transfected with DNA as part of research at the laboratory's campus in the former Brooklyn Army Terminal December 1, 2008 in New York City. The laboratory, seeking a vaccine to prevent the spread of AIDS, is part of the International AIDS Vaccine Initiative (or IAVI), a global not-for-profit, public-private partnership working to accelerate the development of a vaccine to prevent HIV infection and AIDS. December 1 is the 20th annual World AIDS Day around the world. (Photo by) It was a rare moment of bipartisan unity. Standing before a joint session of Congress in January 2019, President Donald Trump boldly pledged to eradicate a disease that claims one life every single minute: HIV/AIDS. 'Scientific breakthroughs have brought a once-distant dream within reach,' Trump exclaimed. 'My budget will ask Democrats and Republicans to make the needed commitment to eliminate the HIV epidemic in the United States within 10 years. We have made incredible strides.' Then, he added, 'we will defeat AIDS in America and beyond.' That was then and this is now. Last week, a group of scientists working on promising HIV vaccine studies were reportedly informed that the administration plans to revoke their research grants in a move experts warn could set the movement back years. When the global AIDS crisis peaked in the early 2000s, roughly 5,000 people were dying every single day from the disease. Thanks to the leadership of governments, the private sector, and philanthropists, the world invested more resources into the AIDS fight than ever before. This spurred nearly two decades of progress—not just against AIDS, but across global health broadly. Since 2004, AIDS-related deaths have been reduced by roughly two-thirds. But recently, progress has slowed. Covid-19 proved a major health disruption that reversed years of hard-fought gains. Efforts to reduce mother-to-child transmission rates have slowed. Global health funding is now under siege not just in the United States, but across Europe, too. And the world is no longer on track to meet critical 2030 AIDS targets. The great paradox here is that never in human history has there been more tools available to fight AIDS. The cost of antiretroviral drugs has fallen from $27 a day in 2000 to as little as 10 cents a day. Now, experts say what's needed to get the fight back on track—and eventually end the threat for good—isn't just better diagnostics and therapeutics, but long acting preventatives. Fortunately, it's an area that's seen great progress. Dubbed the 'breakthrough of the year' in 2024 by the journal Science, Gilead Science's lenacapavir is a long-acting injectable vaccine that has proven incredibly effective at preventing HIV infections. It represents a major step forward from the prevalent pre-exposure prophylaxis (PrEP) pill and mitigates some of the major privacy, stigma, and adherence issues that come with taking daily medication. The next step forward could be a vaccine with even longer immunity—one that gives patients lifetime protection. Researchers have been pursuing this laudable goal for years, but last week, the Trump administration announced plans to terminate research grants at two preeminent institutions, the Duke Human Vaccine Institute and the Scripps Research Institute, totaling $258 million. The researchers were told that the administration wanted 'to go with currently available approaches to eliminate HIV.' On the other hand, global health experts are warning that without new resources, President Trump's promise to end HIV within ten years is destined to fail—and when combined with the administration's other actions to cut and halt global health programs, HIV infections and deaths could actually rise for the first time in decades under his watch. 'I find it very disappointing that, at this critical juncture, the funding for highly successful H.I.V. vaccine research programs should be pulled,' Dennis Burton, an immunologist at Scripps, told The New York Times. Meanwhile AIDS groups, including the AIDS Vaccine Advocacy Coalition described the decision as inconceivable and shortsighted. The grant news marks the latest blow to the HIV/AIDS community, which has endured devastating domestic and global funding cuts in Trump's second term. San Francisco, which was one of the first epicenters of the domestic AIDS fight, has long relied on funding from the federal government to support community-based health programs that help reduce HIV transmission. These initiatives have helped the city make outstanding progress against the disease, but Centers for Disease Control and Prevention (CDC) grant delays have threatened testing, treatment, and care continuity. Even southern states which President Trump won decisively, and which account for 50% of all new U.S. HIV infections, have not been spared. According to the Foundation for AIDS Research (amfAR), cuts to domestic HIV prevention programs could spark over 14,000 additional deaths from AIDS-related causes and 143,000 new HIV infections. Earlier this year, HHS closed its Office of Infectious Diseases & HIV policy that quarterbacked the government's domestic AIDS response. Abroad, global health programs have fared even worse. In January, the Trump administration halted funding for The President's Emergency Plan for AIDS Relief (PEPFAR), a bipartisan program that has saved over 26 million lives. In a congressional hearing last week, Secretary of State Marco Rubio said that, '85 percent of recipients are now receiving PEPFAR services.' He also said that no one has died as a result of the aid freeze, a notion journalists and health experts scoff at. According to Brooke Nichols, an infectious disease mathematical modeler and health economist at Boston University, over 57,000 adults and 6,000 children have died as a result of the PEPFAR funding freeze and the discontinuation of global health programs. Even if those numbers are inflated, as some have contended, the number of lives needlessly lost is still likely in the tens of thousands. While some experts remain hopeful that the recent cuts will eventually be restored, the prospect of an AIDS-free future that President Trump himself once espoused appears grim. "This is a decision with consequences that will linger. This is a setback of probably a decade for HIV vaccine research," Burton warned.


TechCrunch
an hour ago
- TechCrunch
Google says its updated Gemini 2.5 Pro AI model is better at coding
In Brief Google on Thursday announced an update to its Gemini 2.5 Pro preview model that the company claims is better at certain programming tasks. The company's calling it an 'updated preview,' building on the upgrade to Gemini 2.5 Pro that Google announced around a month ago. Google says the model will roll out in general availability in a 'couple of weeks,' and is available starting today in its AI developer platforms AI Studio and Vertex AI and the Gemini app. Image Credits:Google '[Gemini 2.5 Pro] continues to excel at coding, leading on difficult coding benchmarks,' Google writes in a blog post. 'It also shows top-tier performance [on] highly challenging benchmarks that evaluate a model's math, science, knowledge, and reasoning capabilities.' So what else is new? Google says it addressed feedback from its previous 2.5 Pro release, improving the model's style and structure. Now, 2.5 Pro can be 'more creative with better-formatted responses,' Google claims.